Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1356 per EA under NDC 16714079501. Its NADAC has been published 406 times since Nov 14, 2018.
FDA first approved this application on Jul 2, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714079501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078297FDA Approved
7/2/2007
TE Code
AB
On Market Since
7/2/2007
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 406 times since Nov 14, 2018, and over the history we have for it it has declined 11.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.1777 (Aug 11, 2021) |
| All-time low | $0.1158 (Nov 20, 2024) |
| 52-week high | $0.1513 |
| 52-week low | $0.1324 |
| Median price | $0.1557 |
| Average price | $0.1547 |
| Largest weekly change | -21.1% (Nov 20, 2024) |
| Weeks tracked | 406 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1356 per EA (NDC 16714079501), effective Aug 19, 2026.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has declined 11.5%. It has been tracked across 406 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Nov 14, 2018, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1158 (Nov 20, 2024) to a high of $0.1777 (Aug 11, 2021), with a median of $0.1557 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERBINAFINE HCL 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 16714079501) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.